Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Thatcher

Showing results (61-70 of 289) with videos related to

Pageof 29
Sort By:
British Journal of Cancer|August 1, 1996
A phase I study of a 24 hour infusion of gemcitabine in previously untreated patients with inoperable non-small-cell lung cancerH Anderson, N Thatcher, J Walling, et al.
Seminars in Oncology|June 1, 1994
Intensive combined-modality therapy in small cell lung cancerN Thatcher, P Lorrigan, P Burt, et al.
Respiratory Medicine|May 1, 1990
DNA analysis by flow cytometry in nonsmall cell lung cancer: relationship to epidermal growth factor receptor, histology, tumour stage and survivalH Dazzi, N Thatcher, P S Hasleton, et al.
Australian and New Zealand Journal of Medicine|October 1, 1982
Reversible renal failure due to renal cholesterol embolismS W Ho, G N Thatcher, L R Matz
International Journal of Cancer|March 15, 1989
Lack of correlation between peripheral blood lymphokine-activated killer (LAK) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2A K Ghosh, H Dazzi, N Thatcher, et al.
British Journal of Cancer|March 1, 1990
Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: immunological studiesA K Ghosh, M Mellor, J Prendiville, et al.
British Journal of Cancer|April 1, 1986
Genetic predisposition to human lung cancerJ Heighway, N Thatcher, T Cerny, et al.
British Journal of Diseases of the Chest|April 1, 1983
A comparison between a single agent short course chemotherapy regimen and a quadruple prolonged course regimen for small-cell bronchogenic carcinoma of limited extentK B Carroll, H Moussalli, D Brown, et al.
Biochemical Society Transactions|November 1, 1994
Magnetic resonance spectroscopy studies on Ca2+, Zn2+ and energy metabolism in superfused brain slicesH Bachelard, R Badar-Goffer, P Morris, et al.
Cancer Treatment Reviews|June 1, 1989
Recombinant IL-2 given intra-splenically and intravenously in advanced malignant melanoma: a phase I/II studyN Thatcher, H Dazzi, A Gosh, et al.
Pageof 29

Showing results (61-70 of 289) with videos related to

Sort By:
Pageof 29
British Journal of Cancer|August 1, 1996
A phase I study of a 24 hour infusion of gemcitabine in previously untreated patients with inoperable non-small-cell lung cancerH Anderson, N Thatcher, J Walling, et al.
Seminars in Oncology|June 1, 1994
Intensive combined-modality therapy in small cell lung cancerN Thatcher, P Lorrigan, P Burt, et al.
Respiratory Medicine|May 1, 1990
DNA analysis by flow cytometry in nonsmall cell lung cancer: relationship to epidermal growth factor receptor, histology, tumour stage and survivalH Dazzi, N Thatcher, P S Hasleton, et al.
Australian and New Zealand Journal of Medicine|October 1, 1982
Reversible renal failure due to renal cholesterol embolismS W Ho, G N Thatcher, L R Matz
International Journal of Cancer|March 15, 1989
Lack of correlation between peripheral blood lymphokine-activated killer (LAK) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2A K Ghosh, H Dazzi, N Thatcher, et al.
British Journal of Cancer|March 1, 1990
Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: immunological studiesA K Ghosh, M Mellor, J Prendiville, et al.
British Journal of Cancer|April 1, 1986
Genetic predisposition to human lung cancerJ Heighway, N Thatcher, T Cerny, et al.
British Journal of Diseases of the Chest|April 1, 1983
A comparison between a single agent short course chemotherapy regimen and a quadruple prolonged course regimen for small-cell bronchogenic carcinoma of limited extentK B Carroll, H Moussalli, D Brown, et al.
Biochemical Society Transactions|November 1, 1994
Magnetic resonance spectroscopy studies on Ca2+, Zn2+ and energy metabolism in superfused brain slicesH Bachelard, R Badar-Goffer, P Morris, et al.
Cancer Treatment Reviews|June 1, 1989
Recombinant IL-2 given intra-splenically and intravenously in advanced malignant melanoma: a phase I/II studyN Thatcher, H Dazzi, A Gosh, et al.
Pageof 29